Indications: Dilatation of stenotic portions in coronary arteries or stenosis after bypass grafts which replace coronary arteries. Small vessels can also be treated.

Residual stenosis after balloon treatment or endoprosthesis pre/post-dilatation of an endovascular coronary prosthesis, to improve myocardial perfusion.


The paclitaxel-eluting balloon Essential, is a rapid exchange catheter (also known as RX) designed for percutaneous transluminal angioplasties of coronary arteries.

The body of the catheter features a combination of a single lumen at the proximal end and a dual lumen at the distal end.

  • The single lumen at the proximal end allows contrast liquid to pass through between the proximal luer-lock connector and the balloon during in/deflation.
  • The coaxial dual lumen at the distal end has two functions: A lumen to carry the contrast liquid used to inflate the balloon, connected to the proximal lumen and a lumen for the guidewire to facilitate and allow the passage of the catheter towards and through the stenosis to be dilated.


The maximum diameter of the guidewire must not exceed 0.36 mm = 0.014 inches.

On the catheter’s distal part, just before the tip, there is the balloon (inflatable segment) that will dilate the artery upon inflating by means of infusion of contrast fluid.

The balloon is coated with a homogeneous mixture of Paclitaxel, a derivative of Taxol, and a physiologically innocuous matrix, the excipient. The drug’s dose is 3 µg/mm2 of balloon surface and it is intended to avoid cellular proliferation, consequently decreasing re-intervention rate.

The drug is released from the balloon by means of rapid inflation so that a high dose is released in a very short period of time. In order to assure a sufficient dosage of Paclitaxel onto the arterial wall, the inflation process must last from 30 seconds to 1 minute. Dilation of the lesion can be optimized by using longer inflation times at the discretion of the operator.

The balloon is designed to reach different diameters at different pressures, as predicted by the compliance curve included on the primary packaging. Two radiopaque markers are located at each end of the balloon in order to mark its length and help the user to see the catheter while navigating inside the patient.

The Platform-14 Team

We are an independent, imaginative, and dynamic organisation, pioneering a new way for medical distribution in the UK and across Europe. Our team is knowledgeable yet inquisitive, driven but flexible, great at communicating but equally, good listeners.

We believe that our people shape our future and drive our success.

We continuously work to develop our team to help them provide a first-class service for our customers and supplier partners.


Let's Work Together

It’s simple – here at Platform 14 we will work with you, as your partner to drive your sales, market penetration and profitability within your chosen market. In addition, you will benefit from our years of experience launching and cultivating products within the UK and European markets.

At Platform 14, we nurture and take great pride in understanding and expanding our partnership network. We exist for our partners success and welcome new partners into our expanding healthcare product distribution network.

If you are interested in working with Platform-14, please fill out the form below. We look forward to hearing from you.